ATE424191T1 - Ph-unabhängige pharmazeutische formulierungen mit verlängerter freisetzung - Google Patents
Ph-unabhängige pharmazeutische formulierungen mit verlängerter freisetzungInfo
- Publication number
- ATE424191T1 ATE424191T1 AT00904586T AT00904586T ATE424191T1 AT E424191 T1 ATE424191 T1 AT E424191T1 AT 00904586 T AT00904586 T AT 00904586T AT 00904586 T AT00904586 T AT 00904586T AT E424191 T1 ATE424191 T1 AT E424191T1
- Authority
- AT
- Austria
- Prior art keywords
- weight percent
- pharmaceutical formulations
- tablet
- extended release
- release pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24467899A | 1999-02-04 | 1999-02-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE424191T1 true ATE424191T1 (de) | 2009-03-15 |
Family
ID=22923698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00904586T ATE424191T1 (de) | 1999-02-04 | 2000-01-26 | Ph-unabhängige pharmazeutische formulierungen mit verlängerter freisetzung |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1146864B1 (de) |
JP (2) | JP5420126B2 (de) |
AT (1) | ATE424191T1 (de) |
CA (1) | CA2361496C (de) |
CY (1) | CY1108863T1 (de) |
DE (1) | DE60041691D1 (de) |
DK (1) | DK1146864T3 (de) |
ES (1) | ES2321908T3 (de) |
PT (1) | PT1146864E (de) |
WO (1) | WO2000045793A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020025341A1 (en) * | 1998-12-18 | 2002-02-28 | Yihong Qiu | Controlled release formulation of divalproex sodium |
US6419953B1 (en) | 1998-12-18 | 2002-07-16 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
US6511678B2 (en) | 1998-12-18 | 2003-01-28 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
US6528090B2 (en) | 1998-12-18 | 2003-03-04 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
US6713086B2 (en) | 1998-12-18 | 2004-03-30 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
WO2002051402A1 (en) * | 2000-12-22 | 2002-07-04 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
GB0102342D0 (en) * | 2001-01-30 | 2001-03-14 | Smithkline Beecham Plc | Pharmaceutical formulation |
EP1626707A4 (de) * | 2003-02-05 | 2009-07-01 | Yissum Res Dev Co | Formulierung von n-(2-propylpentanoyl)-glycinamid mit verzögerter freisetzung und verwandten verbindungen |
EP1898886B1 (de) | 2005-07-01 | 2019-09-04 | Rubicon Research Pvt Ltd. | Neuartige dosierungsform mit verzögerter freisetzung |
US20100255099A1 (en) * | 2007-10-26 | 2010-10-07 | Rexahn Pharmaceuticals, Inc. | Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders |
CN107811985B (zh) * | 2016-09-13 | 2021-05-28 | 四川科瑞德制药股份有限公司 | 一种抗癫痫缓释制剂及其制备方法与用途 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL72381A (en) * | 1983-07-20 | 1988-03-31 | Sanofi Sa | Pharmaceutical composition based on valproic acid |
US4792452A (en) * | 1987-07-28 | 1988-12-20 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
DE3809764A1 (de) * | 1988-03-23 | 1989-10-05 | Knoll Ag | Mischung aus alginaten und polyacrylaten und deren verwendung |
FR2643556B1 (fr) * | 1989-02-27 | 1993-03-05 | Sanofi Sa | Composition pharmaceutique a liberation prolongee d'acide valproique |
US5102668A (en) * | 1990-10-05 | 1992-04-07 | Kingaform Technology, Inc. | Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH |
DE69617245T2 (de) * | 1995-08-17 | 2002-07-25 | Csir Pretoria | Produkte mit gesteuerter freisetzung |
AUPN969796A0 (en) * | 1996-05-07 | 1996-05-30 | F.H. Faulding & Co. Limited | Taste masked liquid suspensions |
EP0921793B1 (de) * | 1997-03-11 | 2000-10-18 | Hexal Ag | Feste, nicht zerfliessbare formulierung von natrium valproat |
-
2000
- 2000-01-26 WO PCT/US2000/001954 patent/WO2000045793A1/en active Application Filing
- 2000-01-26 JP JP2000596913A patent/JP5420126B2/ja not_active Expired - Lifetime
- 2000-01-26 DK DK00904586T patent/DK1146864T3/da active
- 2000-01-26 CA CA2361496A patent/CA2361496C/en not_active Expired - Fee Related
- 2000-01-26 PT PT00904586T patent/PT1146864E/pt unknown
- 2000-01-26 ES ES00904586T patent/ES2321908T3/es not_active Expired - Lifetime
- 2000-01-26 AT AT00904586T patent/ATE424191T1/de active
- 2000-01-26 EP EP00904586A patent/EP1146864B1/de not_active Expired - Lifetime
- 2000-01-26 DE DE60041691T patent/DE60041691D1/de not_active Expired - Lifetime
-
2009
- 2009-03-06 CY CY20091100254T patent/CY1108863T1/el unknown
-
2011
- 2011-05-24 JP JP2011116089A patent/JP5420590B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2002536318A (ja) | 2002-10-29 |
DK1146864T3 (da) | 2009-05-11 |
CA2361496A1 (en) | 2000-08-10 |
CA2361496C (en) | 2011-06-07 |
CY1108863T1 (el) | 2014-07-02 |
JP5420126B2 (ja) | 2014-02-19 |
JP2011241218A (ja) | 2011-12-01 |
ES2321908T3 (es) | 2009-06-15 |
DE60041691D1 (de) | 2009-04-16 |
EP1146864B1 (de) | 2009-03-04 |
JP5420590B2 (ja) | 2014-02-19 |
WO2000045793A1 (en) | 2000-08-10 |
PT1146864E (pt) | 2009-03-20 |
EP1146864A1 (de) | 2001-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108863T1 (el) | Φαρμακευτικο σκευασμα εκτεταμενης απελευθερωσης ανεξαρτητης απο το ρη | |
ES2376199T3 (es) | Un comprimido farmacéutico caracterizado por mostrar un incremento de volumen cuando entra en contacto con fluidos biológicos. | |
US20100278912A1 (en) | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition | |
KR20030013460A (ko) | 치료제의 위 체류 및 방출 조절을 위한 급속 팽창성조성물과 이 조성물을 포함하는 제형 | |
HUP9800516A2 (hu) | Gyógyszerforma kevéssé oldódó, bázisos gyógyszerhatóanyagok szabályzott felszabadítására | |
HUP0004924A2 (hu) | Ciklodextrineket tartalmazó gyógyászati készítmények | |
EA200200595A1 (ru) | Лекарственная форма с высвобождением лекарства под действием гидрогеля | |
RS20070511A (en) | Modified release pharmaceutical compositions and processes thereof | |
ATE217188T1 (de) | Granulierte pharmazeutische zusammensetzung | |
TNSN98229A1 (fr) | Formulation pharmaceutique orale a liberation prolongee | |
CA2352211A1 (en) | Sustained release matrix systems for highly soluble drugs | |
EP0136103B1 (de) | Amosulalolhydrochlorid-Formulierungen mit lang anhaltender Wirkung | |
JPS6388122A (ja) | 吸収および作用が速やかなサリンダツクまたはサリンダツクナトリウムと塩基の併用剤 | |
CA2383212A1 (en) | Controlled release oral dosage suitable for oral administration | |
JP3247693B2 (ja) | 徐放性製剤 | |
BR0212155A (pt) | Composição farmacêutica | |
SE9603480L (sv) | Beredningsform för svårlösliga läkemedel | |
ES2186207T3 (es) | Metodo para preparacion de formulaciones farmaceuticas. | |
Gupta et al. | Ion exchange resins transforming drug delivery systems | |
IT1303753B1 (it) | Composizioni farmaceutiche somministrabili per via orale contenentiun rivestimento gastroresistente a base di polimeri acrilici. | |
IE840856L (en) | Pharmaceutical composition comprising dipyridamole | |
KR20130121717A (ko) | 위체류 약물전달 시스템을 이용한 서방성 제제 | |
Omidian et al. | Oral targeted drug delivery systems: gastric retention devices | |
Katakam et al. | Floating drug delivery systems: a review | |
Palle | Formulation and Evaluation of Extended Release Hydrogel of an Antiretroviral Drug |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1146864 Country of ref document: EP |